Effect of physiotherapy in treatment of cervicogenic headache

Comparison of the effect of joint mobilization and exercise on pain, range of motion and cervical motor control in patients with chronic cervicogenic headache

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180714040466N1

Enrollment

Registered

2018-12-24

Start date

2018-08-05

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervicogenic headache. Other specified headache syndromes

Interventions

Intervention 1: Intervention group: exercise therapy,The patient will perform exercises for 12 sessions to strengthen the muscles of the area. Intervention 2: Intervention group: mobilization, The Mai

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: History of headache at least 3 months Headache frequency at least one per week At least 5 criteria of CHISG Positive test of upper three cervical intervertebral movements Not receiving of physiotherapy/ chiropractic treatment at least one year ago

Exclusion criteria

Exclusion criteria: Test Positive test for cervical Vertebral Artery and ligaments health

Design outcomes

Primary

Measure	Time frame
Pain ferquency. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: The number of days a person has had a headache last week.;Pain duration. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: average hours pain lasted in past week.;Active cervical ROM. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: Active motion of the neck in the flexion, extension, lateral flexion and right and left rotation, measured by the motion analysis device.;Upper cervical rotation ROM. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: flexion rotation test angle, which is measured by the motion analyzer.;Craniocervical motor control. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: The numerical value of the pressure biofeedback in the craniocervical flexion test.;Headache disability index. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: questionnaire score.;Pain intensity. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: Average pain based on VAS in last week.	—

Measure

Time frame

Pain ferquency. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: The number of days a person has had a headache last week.;Pain duration. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: average hours pain lasted in past week.;Active cervical ROM. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: Active motion of the neck in the flexion, extension, lateral flexion and right and left rotation, measured by the motion analysis device.;Upper cervical rotation ROM. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: flexion rotation test angle, which is measured by the motion analyzer.;Craniocervical motor control. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: The numerical value of the pressure biofeedback in the craniocervical flexion test.;Headache disability index. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: questionnaire score.;Pain intensity. Timepoint: The beginning of treatment, session 6 and 12, one month after the end of treatment. Method of measurement: Average pain based on VAS in last week.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Zakerzadeh

Zahedan University of Medical Sciences

mah.zaker@gmail.com+98 35 3824 5881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026